Filsoufi Farzan, Salzberg Sacha P, Abascal Vivian, Adams David H
Department of Cardiothoracic Surgery, The Mount Sinai Medical Center, New York, NY 10029, USA.
Mt Sinai J Med. 2006 Oct;73(6):874-9.
Moderate-to-severe functional tricuspid regurgitation (TR) should be corrected in patients undergoing surgery for left-sided valvular diseases, to improve long-term outcomes. Several techniques of surgical repair (suture annuloplasty or prosthetic annuloplasty) to correct this condition have been described. Multiple clinical studies have shown the superiority of prosthetic remodeling annuloplasty over the other surgical approaches. Despite this, suture-based annuloplasty remains the most commonly used technique for tricuspid valve repair. A new 3-dimensional remodeling prosthesis has been developed to address the issue of residual TR. We report our early experience with this new 3-dimensional prosthetic remodeling ring, the Edwards MC 3 system.
From August 2002 to March 2004, 51 patients (24 male, 27 female, mean age 64 +/- 15, ejection fraction 49 +/- 15, median NYHA III [II-IV]) underwent tricuspid valve repair for functional TR due to annular dilatation, with the Edwards MC 3 system. Etiology of left-sided valvular disease was: rheumatic (n = 19), degenerative (n = 16), ischemic cardiomyopathy (n = 1), and endocarditis (n = 5). Twenty (50%) patients underwent redo operations. Concomitant procedures included: mitral valve surgery (repair n = 34, replacement n = 14), aortic valve replacement (n = 5), coronary artery bypass graft (n = 8) and left arterial maze (n = 16). Median EuroSCORE was 12% (1-74%) in this patient population.
Operative and late mortality were 3.8% (n = 2) and 13.7% (n = 7), respectively. Echocardiography at discharge showed a mean TR decrease from 3.1 +/- 0.9 to 0.3 +/- 0.4 (p < 0.001) and mean mitral regurgitation (MR) decrease from 3.2 +/- 1 to 0.1 +/- 0.1 (p < 0.001), while ejection fraction increased to 53% (p = 0.047), and at 6-month follow-up, mean TR and MR remained unchanged.
Concomitant tricuspid valve repair for functional TR with left-sided valve surgery carries a low operative mortality. The Edwards MC 3 annuloplasty system is relatively simple to implant and corrects TR effectively (without significant residual TR), while providing excellent short-term clinical results. The 3-dimensional saddle shape of this ring may further optimize the fixation of the annulus in systolic position, and improve long-term results. Larger clinical series with longer-term follow-up are necessary to confirm these early promising results.
对于接受左侧瓣膜疾病手术的患者,应矫正中重度功能性三尖瓣反流(TR),以改善长期预后。已描述了几种用于矫正这种情况的手术修复技术(缝合瓣环成形术或人工瓣环成形术)。多项临床研究表明,人工瓣环重塑成形术优于其他手术方法。尽管如此,基于缝合的瓣环成形术仍然是三尖瓣修复最常用的技术。已开发出一种新的三维重塑假体来解决残余TR的问题。我们报告了我们使用这种新型三维人工瓣环重塑环(Edwards MC 3系统)的早期经验。
2002年8月至2004年3月,51例患者(男24例,女27例,平均年龄64±15岁,射血分数49±15,纽约心脏协会心功能分级中位数为III级[II-IV级])因瓣环扩张接受了使用Edwards MC 3系统的功能性TR三尖瓣修复术。左侧瓣膜疾病的病因包括:风湿性(n = 19)、退行性(n = 16)、缺血性心肌病(n = 1)和心内膜炎(n = 5)。20例(50%)患者接受了再次手术。同期手术包括:二尖瓣手术(修复n = 34,置换n = 14)、主动脉瓣置换(n = 5)、冠状动脉旁路移植术(n = 8)和左心房迷宫手术(n = 16)。该患者群体的欧洲心脏手术风险评估系统(EuroSCORE)中位数为12%(1%-74%)。
手术死亡率和晚期死亡率分别为3.8%(n = 2)和13.7%(n = 7)。出院时超声心动图显示平均TR从3.1±0.9降至0.3±0.4(p < 0.001),平均二尖瓣反流(MR)从3.2±1降至0.1±0.1(p < 0.001),而射血分数增加至53%(p = 0.047),在6个月随访时,平均TR和MR保持不变。
在进行左侧瓣膜手术时同期进行功能性TR三尖瓣修复,手术死亡率较低。Edwards MC 3瓣环成形术系统植入相对简单,能有效矫正TR(无明显残余TR),同时提供优异的短期临床结果。该环的三维鞍形可能进一步优化瓣环在收缩期位置的固定,并改善长期结果。需要更大规模的临床系列研究和更长时间的随访来证实这些早期的良好结果。